Sign in
4

Changes in Ownership

INSMED Inc Filed Acc 0001628280-25-004076

Chair and CEO sold 25,580 shares at an average $77.94 ($1,993,731)

  • Chair and CEO acquired 25,580 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lewis William Chair and CEO 2025-02-03 Option exercise 10b5-1 +18,750 $22.76 $426,750 398,284 D: show line 1 in the form
Lewis William Chair and CEO 2025-02-03 Sale 10b5-1 −241 $75.25 $18,135 398,043 D: show line 2 in the form
Lewis William Chair and CEO 2025-02-03 Sale 10b5-1 −1,872 $76.35 $142,927 396,171 D: show line 3 in the form
Lewis William Chair and CEO 2025-02-03 Sale 10b5-1 −9,869 $77.97 $769,486 386,302 D: show line 4 in the form
Lewis William Chair and CEO 2025-02-03 Sale 10b5-1 −6,768 $78.44 $530,882 379,534 D: show line 5 in the form
Lewis William Chair and CEO 2025-02-03 Option exercise 10b5-1 +6,830 $10.85 $74,106 240,754 I: show line 6 in the form
Lewis William Chair and CEO 2025-02-03 Sale 10b5-1 −41 $74.86 $3,069 240,713 I: show line 7 in the form
Lewis William Chair and CEO 2025-02-03 Sale 10b5-1 −745 $76.43 $56,940 239,968 I: show line 8 in the form
Lewis William Chair and CEO 2025-02-03 Sale 10b5-1 −3,463 $77.95 $269,941 236,505 I: show line 9 in the form
Lewis William Chair and CEO 2025-02-03 Sale 10b5-1 −2,581 $78.40 $202,350 233,924 I: show line 10 in the form
Open-market sales · 25,580 sh · avg $77.94 · $1,993,731

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Lewis William Chair and CEO 2025-02-03 Option exercise · Stock Option (right to buy) 10b5-1 −18,750 56,250 D: show line 11 in the form
Lewis William Chair and CEO 2025-02-03 Option exercise · Stock Option (right to buy) 10b5-1 −6,830 211,800 I: show line 12 in the form
Loading xslF345X05/wk-form4_1738791860.xml…